These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22949899)

  • 1. A pediatric case of pityriasis rubra pilaris successfully treated with low-dose vitamin a.
    Koga M; Koga K; Nakayama J
    Case Rep Dermatol; 2012 May; 4(2):170-3. PubMed ID: 22949899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circumscribed Juvenile Pityriasis Rubra Pilaris (Type 4) Koebnerising after a Hot Water Burn: Mild Disease with Maximum Koebner Response.
    Acar EM; Has S; Kilitci A; Kemeriz F
    Acta Dermatovenerol Croat; 2019 Mar; 27(1):47-49. PubMed ID: 31032794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate treatment in a case of juvenile pityriasis rubra pilaris.
    Boyd AH; Polcari IC
    Pediatr Dermatol; 2018 Jan; 35(1):e62-e63. PubMed ID: 29044698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris.
    Di Stefani A; Galluzzo M; Talamonti M; Chiricozzi A; Costanzo A; Chimenti S
    J Dermatol Case Rep; 2013 Mar; 7(1):5-9. PubMed ID: 23580907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late onset pityriasis rubra pilaris type IV treated with low-dose acitretin.
    Mota F; Carvalho S; Sanches M; Selores M
    Acta Dermatovenerol Alp Pannonica Adriat; 2016; 25(1):15-7. PubMed ID: 27014774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pityriasis rubra pilaris partially responsive to treatment with upadacitinib: A case report.
    Saad M; Spurr A; Lipson J
    SAGE Open Med Case Rep; 2023; 11():2050313X231160927. PubMed ID: 37009550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pityriasis rubra pilaris: a review of diagnosis and treatment.
    Cohen PR; Prystowsky JH
    J Am Acad Dermatol; 1989 May; 20(5 Pt 1):801-7. PubMed ID: 2654219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrodermic pityriasis rubra pilaris treatment: Two case reports and literature review.
    Camela E; Miano C; Di Caterino P; Lo Presti M; De Fata Salvatores G; Fabbrocini G; Megna M
    Dermatol Ther; 2020 Nov; 33(6):e14223. PubMed ID: 32820849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic pityriasis rubra pilaris in association with prostate carcinoma: A case report and literature review.
    Fekete GL; Boda D; Căruntu C; Fekete L
    Exp Ther Med; 2019 Dec; 18(6):5052-5055. PubMed ID: 31798725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic hotline. Treatment of pityriasis rubra pilaris with etanercept.
    Guedes R; Leite L
    Dermatol Ther; 2011; 24(2):285-6. PubMed ID: 21410618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of refractory pityriasis rubra pilaris: challenges and solutions.
    Moretta G; De Luca EV; Di Stefani A
    Clin Cosmet Investig Dermatol; 2017; 10():451-457. PubMed ID: 29184428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ustekinumab as an alternative treatment option for chronic pityriasis rubra pilaris.
    Chowdhary M; Davila U; Cohen DJ
    Case Rep Dermatol; 2015; 7(1):46-50. PubMed ID: 25969677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab-induced pityriasis rubra pilaris-like eruption.
    Brown S; Fletcher JW; Fiala KH
    Proc (Bayl Univ Med Cent); 2016 Jul; 29(3):335-6. PubMed ID: 27365893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult onset pityriasis rubra pilaris.
    Sehgal VN; Srivastava G; Dogra S
    Indian J Dermatol Venereol Leprol; 2008; 74(4):311-21. PubMed ID: 18797049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secukinumab monotherapy successfully treated severe refractory type V (atypical juvenile) pityriasis rubra pilaris: A case report and literature review.
    Liang JY; Ye RX; Tian X; Zhang SQ; Zhang XB
    Dermatol Ther; 2020 Nov; 33(6):e14097. PubMed ID: 32725719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pityriasis rubra pilaris as a systemic disease.
    Kamarachev J; Grozdev I; Darlenski R; Tsankov N
    Clin Dermatol; 2019; 37(6):657-662. PubMed ID: 31864444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report: Area of focus of management of severe pityriasis rubra pilaris by dose optimization of adalimumab biosimilar in combination with acitretin and montelukast.
    Heidemeyer K; Seyed Jafari SM; Farnina L; Bossart S; Feldmeyer L; Yawalkar N
    Front Med (Lausanne); 2023; 10():1295777. PubMed ID: 38098840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Treatment of Pityriasis Rubra Pilaris with Risankizumab in Children.
    Kołt-Kamińska M; Osińska A; Kaznowska E; Reich A
    Dermatol Ther (Heidelb); 2023 Oct; 13(10):2431-2441. PubMed ID: 37704911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pityriasis rubra pilaris sensitive to narrow band-ultraviolet B light therapy.
    Vergilis-Kalner IJ; Mann DJ; Wasserman J; Petronic-Rosic V; Tsoukas MM
    J Drugs Dermatol; 2009 Mar; 8(3):270-3. PubMed ID: 19271375
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.